The carrying value of goodwill was $6.3 million as of December 1, 2018 and June 2, 2018. The goodwill balance in its entirety relates to our IMES reporting unit, which is included in our Healthcare segment.

Goodwill is initially recorded based on the premium paid for acquisitions and is subsequently tested for impairment, using the first day of our fourth quarter as the measurement date. We test goodwill for impairment annually and whenever events or circumstances indicate an impairment may have occurred, such as a significant adverse change in the business climate, an adverse action or assessment by a regulator, unanticipated competition, loss of key personnel or a decision to sell or dispose of a reporting unit.

During the first six months of fiscal 2019, no events or circumstances were identified that would indicate impairment may have occurred. Although we believe our projected future operating results and cash flows and related estimates regarding fair values were based on reasonable assumptions, historically, projected operating results and cash flows have not always been achieved. Changes in any of the significant assumptions used, including if the Company does not successfully achieve its operating plan, which is largely dependent on sales from new product offerings, can materially affect the expected cash flows, and such impacts could result in a material non-cash impairment charge of goodwill and other long lived assets.

Potential events or changes in circumstances that could reasonably be expected to negatively affect key assumptions are deterioration in general market conditions or the environment in which the reporting unit or entity operates, an increased competitive environment in which the reporting unit or entity operates or other relevant entity-specific events such as market acceptance of our new CT tubes and other new product offerings, approvals to sell in foreign markets and changes in management or key personnel.

Our intangible assets represent the fair value for trade name, customer relationships, non-compete agreements and technology acquired in connection with our acquisitions. Intangible assets subject to amortization are as follows (in thousands):

	December 1, 2018		June 2, 2018
Gross Amounts:
Trade Name	$	659	$	659
Customer Relationships⁽¹⁾		3,396		3,408
Non-compete Agreements		177		177
Technology		230		230
Total Gross Amounts	$	4,462	$	4,474
Accumulated Amortization:
Trade Name	$	655	$	651
Customer Relationships		703		617
Non-compete Agreements		127		115
Technology		90		77
Total Accumulated Amortization	$	1,575	$	1,460

Net Intangibles	$	2,887	$	3,014

(1)	Change from prior periods reflect impact of foreign currency translation.

The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table (in thousands):

Fiscal Year	Amortization Expense
Remaining 2019	$	123
2020		257
2021		245
2022		252
2023		245
Thereafter		1,765
Total amortization expense	$	2,887

The weighted average number of years of amortization expense remaining is 15.1 years.